Cannabidiol Medication Intervention Trial

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 27, 2023

Primary Completion Date

December 29, 2026

Study Completion Date

December 29, 2026

Conditions
Alzheimer Disease
Interventions
DRUG

CBD

Participants in this arm will receive CBD for 8 weeks during the first treatment period. They will then receive a two-week single-blind placebo washout before moving into the second 8-week treatment period, during which they will receive the opposite study treatment than the one given in the first treatment period.

OTHER

Placebo

Participants in this arm will receive placebo for 8 weeks during the first treatment period. They will then receive a two-week single-blind placebo washout before moving into the second 8-week treatment period, during which they will receive the opposite study treatment than the one given in the first treatment period.

Trial Locations (5)

T2N 4N1

NOT_YET_RECRUITING

University of Calgary, Calgary

Unknown

NOT_YET_RECRUITING

London Health Sciences Centre, London

NOT_YET_RECRUITING

Centre for Addiction and Mental Health, Toronto

M3H0A7

RECRUITING

Sunnybrook Health Sciences Centre, Toronto

L1N 5S9

RECRUITING

Ontario Shores Centre for Mental Health Sciences, Whitby

All Listed Sponsors
collaborator

Weston Brain Institute

OTHER

lead

Sunnybrook Health Sciences Centre

OTHER